OUTREACH: Phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL

Publication Date

2024

Content Type

Article

PubMed ID:

39347584

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS